a pipeline POWERED BY PASSION

Pipeline
We're advancing muscle-directed potential treatments for diseases characterized by compromised muscle function, muscle weakness, and fatigue.
Cardiovascular
Research
Pre-Clinical
Phase 1
Phase 2
Phase 3
CK-586
Cardiac Myosin Inhibitor
HFpEF
Research
Pre-Clinical
Phase 1
Phase 2
Phase 3
Research
Pre-Clinical
Phase 1
Phase 2
Phase 3
Research
Pre-Clinical
Phase 1
Phase 2
Phase 3
Research
Pre-Clinical
Phase 1
Phase 2
Phase 3
Research
Pre-Clinical
Phase 1
Phase 2
Phase 3
Neuromuscular
Additional skeletal
muscle activators
Research
Pre-Clinical
Phase 1
Phase 2
Phase 3
Research
Pre-Clinical
Phase 1
Phase 2
Phase 3
Other
Muscle biology-directed research
Research
Pre-Clinical
Phase 1
Phase 2
Phase 3
Approved
Cardiovascular
Cardiac Myosin Activator; Heart failure, other
Research
Pre-Clinical
Phase 1
CK-586
Research
Pre-Clinical
Phase 1
Neuromuscular
Fast Skeletal Muscle Troponin Activator; ALS
Research
Pre-Clinical
Phase 1
Phase 2
Phase 3
Additional skeletal muscle activators
Research
Pre-Clinical
Other
Muscle biology-directed research
Research
All drug candidates are investigational and are not approved by any regulatory agency. Their safety and effectiveness have not been established.